Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Soluble isoforms of EGFR family in breast cancer: Advances and clinical relevance (Review).

Oncology letters·2026

Same author

Targeting the tumor immune microenvironment: GPCRs as key regulators in triple-negative breast cancer.

International immunopharmacology·2024

Same author

Small molecule tyrosine kinase inhibitors approved for systemic therapy of advanced hepatocellular carcinoma: recent advances and future perspectives.

Discover oncology·2024

Same author

Two Transient Receptor Potential Channels at Focal Adhesions.

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society·2023

Same author

Conformations, interactions and functions of intrinsically disordered syndecans.

Biochemical Society transactions·2023

Same author

GABA<sub>B1e</sub> promotes the malignancy of human cancer cells by targeting the tyrosine phosphatase PTPN12.

iScience·2021

Search research articles

Related Experiment Video

Updated: May 26, 2026

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

Perlecan and tumor angiogenesis.

Xinnong Jiang¹, John R Couchman

¹Department of Cell Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society

|October 21, 2003

Summary

This summary is machine-generated.

Perlecan, a key heparan sulfate proteoglycan (HSPG), is vital for tissue structure and growth factor binding. Dysregulation of perlecan

More Related Videos

Isolation and Culture Expansion of Tumor-specific Endothelial Cells

Isolation and Culture Expansion of Tumor-specific Endothelial Cells

Published on: October 14, 2015

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

Published on: June 2, 2022

Related Experiment Videos

Last Updated: May 26, 2026

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

Isolation and Culture Expansion of Tumor-specific Endothelial Cells

Isolation and Culture Expansion of Tumor-specific Endothelial Cells

Published on: October 14, 2015

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

Published on: June 2, 2022

Area of Science:

Biochemistry
Molecular Biology
Cell Biology

Background:

Perlecan is a major heparan sulfate proteoglycan (HSPG) found in basement membranes and connective tissues.
Its core protein has five domains, with domain I typically bearing three heparan sulfate (HS) chains that bind matrix molecules, cytokines, and growth factors.
Perlecan is essential for metazoan life, with mutations in humans being potentially lethal.

Purpose of the Study:

To review the diverse functions of perlecan, particularly in vertebrates.
To explore the role of perlecan in binding and presenting growth factors to tyrosine kinase (TK) receptors.
To discuss the implications of perlecan's growth factor-mediated functions in tumor cell proliferation and angiogenesis.

Main Methods:

Literature review and synthesis of existing research on perlecan.
Analysis of perlecan's molecular structure and its interactions with growth factors and receptors.
Discussion of genetic and mutational data related to perlecan function and dysfunction.

Main Results:

Perlecan plays crucial roles in vertebrate development, including the vascular and skeletal systems.
Its ability to bind and present growth factors is central to many of its functions.
Accumulating evidence suggests perlecan contributes to tumor progression through growth factor signaling.

Conclusions:

Perlecan's multifaceted roles in growth factor presentation are critical for normal physiology.
Understanding perlecan's involvement in tumor angiogenesis and proliferation offers potential therapeutic targets.
Further molecular-level investigation of perlecan may lead to novel cancer treatment strategies.